Hep Spring 2018 - Special Issue
Hep Spring 2018 - Special Issue
In every issue of Hep, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Profile
Advocacy in Action
Ryan Clary, executive director of the National Viral Hepatitis Roundtable, sits at the helm of U.S. efforts to end the epidemic.
From The Editor
Best of You
Awareness and funding continue to be major challenges when it comes to viral hepatitis advocacy.
News
Is U.S. Lagging in Hepatitis Efforts?
Nine countries are currently on track to eliminate HCV and HBV by 2030, but the United States is not among them.
As Injection Drug Use Rises, So Does Hep C
The national increase in acute HCV infection is related to the country’s opioid epidemic and associated increases in injection drug use.
Philadelphia OKs Safe Injection Facility
The city wants to reduce its number of opioid-related deaths.
“Treatment as Prevention” to Fight Hep C
Using TasP to cure hepatitis C could help prevent new transmissions of the virus.
Treatment News
An Early Cure Protects the Liver?
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
Cured of Hep C, at Risk of Fatty Liver
In a recent study, half of those cured of hepatitis C developed signs of non-alcoholic fatty liver disease (NAFLD).
Reducing Hospital Costs
Treating hepatitis C among those with cirrhosis reduces hospitalizations.
Addiction Specialists List Barriers to HCV Treatment
By modifying these barriers, clinicians hope to treat more hep C among patients undergoing opioid addiction treatment.
